MCD vs TXMD · P/E 23, rev $25.92B vs rev $1.8M
McDonald’s Corporation (MCD) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the MCD and TXMD stock pages for the full models.
Not investment advice.